Results 11 to 20 of about 1,084,654 (294)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers

open access: yesMedicina, 2021
Beta-blockers are a class of drugs with important benefits in cardiovascular pathology. In this paper, we aim to highlight their adverse and therapeutic effects in the neuropsychiatric field.
Sabina Alexandra Cojocariu   +5 more
doaj   +2 more sources

Beta-blockers for hypertension [PDF]

open access: yesCochrane Database of Systematic Reviews, 2017
Beta-blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long-term beneficial effects on mortality and cardiovascular disease (CVD) when used in people with heart failure or acute myocardial infarction. Beta-blockers were thought to have similar beneficial effects when used as first-line
Wiysonge, Charles S.   +4 more
openaire   +5 more sources

Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension

open access: yesHearts
Background: Even though beta-blockers had been used as a first-line therapy for hypertension, since the late 1960s, the Eighth Joint National Committee, JNC 8, decided to recommend them no longer.
Maryam Izadi   +2 more
doaj   +2 more sources

Impact of beta2-agonists, beta-blockers, and their combination on cardiac function in elderly male patients with chronic obstructive pulmonary disease

open access: yesClinical Interventions in Aging, 2013
Long-Huan Zeng,1,* Yi-Xin Hu,2,* Lin Liu,2 Meng Zhang,1 Hua Cui1 1Second Geriatric Cardiology Division, 2Clinical Department of Geriatrics, Chinese PLA General Hospital, Beijing, People's Republic of China *These authors contributed equally to this ...
Zeng LH, Hu YX, Liu L, Zhang M, Cui H
doaj   +1 more source

Poor tolerance of beta-blockers by elderly patients with heart failure

open access: yesClinical Interventions in Aging, 2010
Satoshi Yanagisawa, Noriyuki Suzuki, Toshikazu TanakaDepartment of Cardiology, Okazaki City Hospital, Aichi, JapanAbstract: Despite the well-understood importance of beta-blocker therapy in heart failure, it is sometimes not possible to use beta-blockers
Satoshi Yanagisawa   +2 more
doaj   +1 more source

Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD

open access: yesInternational Journal of COPD, 2009
Yvette RBM van Gestel1, Sanne E Hoeks1, Don D Sin2, Henk Stam3, Frans W Mertens3, Jeroen J Bax4, Ron T van Domburg5, Don Poldermans61Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands; 2Department of Medicine ...
Yvette RBM van Gestel   +7 more
doaj   +1 more source

Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence

open access: yesVascular Health and Risk Management, 2010
Janet B McGillDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USAAbstract: Hypertension is the number one diagnosis made by primary care physicians, placing them in a unique position to prescribe the ...
Janet B McGill
doaj   +1 more source

Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study

open access: yesFrontiers in Pharmacology, 2021
Objectives: Rheumatoid arthritis (RA) is an independent nontraditional risk factor for incidence of myocardial infarction (MI) and post-MI outcome is impaired in the RA population.
Sheng-Fu Liu   +14 more
doaj   +1 more source

The use of beta-blockers before major trauma and posttrauma outcome: A nationwide population-based study

open access: yesJournal of Medical Sciences, 2022
Background: Beta-blockers are widely used for the treatment of arrhythmia, hypertension, and congestive heart failure. Major trauma causes significant blood loss and subsequent tachycardia and hypotension.
Jen-Chun Wang   +5 more
doaj   +1 more source

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2020
Beta blockers are a recommended therapy in patients with heart failure with reduced ejection fraction(HFrEF). Beta blockers markedly and unequivocally reduce mortality in patients with heart failure with reduced ejection fraction. However, the beneficial
Xizhen Xu, Dao Wen Wang
doaj   +1 more source

Home - About - Disclaimer - Privacy